timothy sykes logo
Cannabis Stocks Surge on News of U.S. Policy Shift Thumbnail

Cannabis Stocks Surge on News of U.S. Policy Shift

BRYCE TUOHEYUPDATED DEC. 18, 2025, 11:33 AM ET
Reviewed by Tim Sykes Fact-checked by Matt Monaco

SNDL Inc.’s stocks have been trading up by 9.18 percent amid promising sentiment for stronger cannabis market growth.

Candlestick Chart

Live Update At 11:32:42 EST: On Thursday, December 18, 2025 SNDL Inc. stock [NASDAQ: SNDL] is trending up by 9.18%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Peeking into the financial lens reveals a rollercoaster of numbers for SNDL. The company’s recent earnings show revenue reaching $920M, yet it has taken a hit with net income from continuing operations standing at a loss of $13.32M in Q3 2025. With a profitability margin still wrestling to stay in the positive zone, SNDL grapples with an EBIT margin of -4.1%, highlighting the ongoing battle with cost management.

A closer look at stock data shows that SNDL’s share price trotted a path of ups and downs, consistently maintaining bursts of highs and lows. On Dec 18, 2025, the stock rose to a high of 2.34 from an opening of 2.14, reflecting a market still digesting the potential policy changes stateside.

The current sentiment, buoyed by recent announcements, foresaw positive developments for SNDL’s finances. The approval renewal of SNDL’s share repurchase program signals confidence from the top guns. This allows SNDL to scoop up to $70.9M of its outstanding shares by Nov 2026, potentially steering the stock price upwards, allowing them to pull back their sails in turbulent waters.

Market Reactions: A Tale of Two Policies

When a whisper of Washington changing its tune on marijuana floated through trading floors, it was like sparking a fire in a dry wood. News that President Trump might steer cannabis policy towards a friendlier frontier fueled quick rallies, revealing investor readiness to back these budding opportunities. Shares fluttered wildly as SNDL, alongside other cannabis comrades like Canopy Growth and Tilray, watched their values shoot up—like fireworks spreading joy on a festive night. This surge wasn’t just numbers on a screen but a depiction of political shifts now potentially backing a rapidly insatiable market desire.

More Breaking News

The pivot point? A potential reclassification of marijuana as a less potent drug—shifting it into the zone of prescription medications rather than an outlawed substance. Trading floors, illuminated by computer screens ablaze with green, showed SNDL gaining after such reports, reflecting investor optimism dancing to the tune of policy harmonizing with market desires.

Competitive Pressures: Walking the Tightrope

For SNDL, the challenges extend beyond regulatory landscapes into an arena juggled by financial figures prodding both above and below the line. The company’s gross margin stands comfortably at 47.5%, yet it operates under the pressure of an asset turnover of merely 0.7—underscoring productivity challenges that still hang heavily over SNDL’s head.

The hard shell of competition encases an industry that craves growth. The reports of share buybacks underscore SNDL’s attempts to solidify their foothold. Their financial chess pieces are moved cautiously, with eyeing efficiency pressing on the mind. With a current ratio optimistically positioned at 5, SNDL aims to stay clear of immediate liquidity issues, yet the path ahead prompts constant vigilance.

Conclusion

Amidst buzzing news and fluctuating figures, SNDL stands in a watchful position, balancing eagerly rising trader sentiment against underlying financial nuances. The whispers of policy relaxation act as a gust of wind, potentially pushing sails toward prosperous seas. Yet, undercurrents of economic figures remind traders to steer mindfully. As millionaire penny stock trader and teacher Tim Sykes, says, “It’s not about how much money you make; it’s about how much money you keep.” This wisdom echoes the importance of strategic trading decisions amidst market volatility.

Whether these policy shifts manifest fully remains shrouded in political corridors, but as things stand, SNDL finds itself in a unique moment where expectations flutter amidst evolving narratives, continuously pulsing with the rhythm of market tales spun from Washington to Wall Street.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:



How much has this post helped you?


Leave a reply

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SNDL

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”